Francis Giles, MB, MD, FRCPI, FRCPath, has been appointed Chief of the Division of Hematology/Oncology in the Department of Medicine at Northwestern. In his new role, he will continue to advance the division’s clinical, research, and academic pursuits.
Dr. Giles joined the faculty of the Division of Hematology/Oncology in 2013. Since then, he has led the launch and growth of the Northwestern Medicine Developmental Therapeutics Institute (NMDTI). He also started the NMDTI Developmental Therapeutics Fellowship, which offers a mentorship environment for clinical investigators. In 2014, he was appointed Deputy Director of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University.
Dr. Giles has focused his clinical and research efforts on providing therapy for patients suffering from treatment-resistant or refractory cancer. He has pioneered the use of many agents that are now in regular use as targeted therapies for patients with cancer.
Dr. Giles is a fellow of the European Academy of Cancer Sciences, the Royal College of Physicians of Ireland, and the Royal College of Pathologists.
Before joining Feinberg, Dr. Giles served as Director the Institute for Drug Development and Deputy Director of the Cancer Therapy and Research Center at the University of Texas Health Science Center in San Antonio. ■